IViR Lecture Series: Regulating Femtech: Addressing Regulatory Gaps in Women’s Health Technologies

The proliferation of femtech—technologies designed to monitor, manage, or enhance aspects of women’s health— poses novel challenges for contemporary regulatory and legal frameworks. Operating at the boundaries of medical devices, consumer products, and digital platforms, many femtech innovations fall into the gaps between existing law and regulation. Using contraception and fertility-focused femtech by way of example, this talk examines how regulatory systems in the UK (drawn from EU frameworks such as the GDPR and EU MDR) regulate, or fail to regulate, femtech products and the sensitive personal data they generate. It argues that prevailing approaches to classification, risk assessment, and consent are ill-suited to the hybrid and data-intensive nature of femtech, leaving both consumers and innovators exposed to uncertainty. The analysis highlights the need for reflexive and intersectional regulatory approaches to fill these gaps that prioritise, rather than ignore, risks femtech poses to women’s health and wellbeing.